UNITED THERAPEUTICS news, videos and press releases - Page 5
For more news please use our advanced search feature.
UNITED THERAPEUTICS - More news...
UNITED THERAPEUTICS - More news...
- United Therapeutics Issues Statement In Response To Meritless Lawsuit
- United Therapeutics Announces BEAT Study of Esuberaprost Does Not Meet Primary Endpoint
- United Therapeutics Corporation to Present at Oppenheimer 29th Annual Healthcare Conference
- United Therapeutics Corporation To Present At Cowen And Company 39th Annual Health Care Conference
- United Therapeutics Corporation Reports 2018 Fourth Quarter And Annual Financial Results
- United Therapeutics Corporation To Report Fourth Quarter And Annual 2018 Financial Results Before The Market Opens On Wednesday, February 27, 2019
- Survival Data From FREEDOM-EV Study of Orenitram Presented at the Pulmonary Vascular Research Institute Annual World Congress
- United Therapeutics Corporation To Present At 37th Annual J.P. Morgan Healthcare Conference
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of United Therapeutics Corporation - UTHR
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of United Therapeutics Corporation - UTHR
- Health Canada Approves Unituxin® For The Treatment Of Pediatric High-Risk Neuroblastoma
- Report: Exploring Fundamental Drivers Behind Harvard Bioscience, TTM Technologies, BSQUARE, United Therapeutics, KCAP Financial, and Gladstone Capital — New Horizons, Emerging Trends, and Upcoming Developments
- CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
- Nilda Mesa Joins The United Therapeutics Corporation Board Of Directors
- United Therapeutics Corporation Reports Third Quarter 2018 Financial Results
- United Therapeutics Corporation To Report Third Quarter 2018 Financial Results Before The Market Opens On Wednesday, October 31, 2018
- CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
- CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
- United Therapeutics And MannKind Announce Closing Of License And Collaboration Agreement
- United Therapeutics Corporation To Host Science Day 2018
- Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate
- Correvio Highlights Completion of SteadyMed Acquisition by United Therapeutics
- United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products
- United Therapeutics Corporation Completes Acquisition Of SteadyMed Ltd.
- United Therapeutics Announces Settlement Of Patent Litigation With Watson Laboratories, Inc. Relating To Tyvaso
- United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint
- United Therapeutics Corporation To Present At 2018 Wedbush PacGrow Healthcare Conference
- United Therapeutics Corporation Reports Second Quarter 2018 Financial Results
- United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®
- United Therapeutics Corporation To Report Second Quarter 2018 Financial Results Before The Market Opens On Wednesday, August 1, 2018